{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:42:20Z","timestamp":1791423740727,"version":"4.3.3"},"reference-count":44,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,7,1]]},"abstract":"<jats:p>To characterize mitral and aortic valve abnormalities we performed M-mode, two-dimensional, and pulsed Doppler echocardiography in 42 patients with active acromegaly, 22 patients cured of acromegaly, and 64 controls pair-matched with the patients for sex and age. The overall prevalence of valve abnormalities was higher in both the active patients (86% vs. 24%; P &amp;lt; 0.0001) and the cured patients (73% vs. 9%; P &amp;lt; 0.0001) than in controls. Left ventricular hypertrophy was higher in active (81% vs. 29%; P &amp;lt; 0.0001), but not in cured (41% vs. 14%; P = 0.09) patients than in controls. Cardiac valve abnormalities were associated with left ventricular hypertrophy in both patients and controls, without any difference between them. Conversely, among subjects without left ventricular hypertrophy, mitral and aortic abnormalities were only present in the patients (75% of active and 54% of cured), but not in controls (3% of active controls and 0% of cured controls).<\/jats:p>\n               <jats:p>In conclusion, patients with active acromegaly and those cured of the disease have a high prevalence of mitral and aortic abnormalities. The persistence of valve disease in patients with cured acromegaly is likely to be correlated with the persistence of left ventricular hypertrophy, which should be carefully and continuously monitored as an aspect of the risk of cardiac dysfunction in these patients.<\/jats:p>","DOI":"10.1210\/jc.2002-021099","type":"journal-article","created":{"date-parts":[[2003,7,3]],"date-time":"2003-07-03T22:15:57Z","timestamp":1057270557000},"page":"3196-3201","source":"Crossref","is-referenced-by-count":117,"title":["High Prevalence of Cardiac Valve Disease in Acromegaly: An Observational, Analytical, Case-Control Study"],"prefix":"10.1210","volume":"88","author":[{"given":"Annamaria","family":"Colao","sequence":"first","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.C., P.M., R.P., C.D.S., G.V., G.L.), 80123 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Spinelli","sequence":"additional","affiliation":[{"name":"Internal Medicine I (L.S., M.P., D.B.), Federico II University of Naples, 80123 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Marzullo","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.C., P.M., R.P., C.D.S., G.V., G.L.), 80123 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.C., P.M., R.P., C.D.S., G.V., G.L.), 80123 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Petretta","sequence":"additional","affiliation":[{"name":"Internal Medicine I (L.S., M.P., D.B.), Federico II University of Naples, 80123 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Di Somma","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.C., P.M., R.P., C.D.S., G.V., G.L.), 80123 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vitale","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.C., P.M., R.P., C.D.S., G.V., G.L.), 80123 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Bonaduce","sequence":"additional","affiliation":[{"name":"Internal Medicine I (L.S., M.P., D.B.), Federico II University of Naples, 80123 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.C., P.M., R.P., C.D.S., G.V., G.L.), 80123 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071618502440600_R1","first-page":"1","article-title":"Mortality in acromegaly.","volume":"39","author":"Wright","year":"1970","journal-title":"Q J Med"},{"key":"2020071618502440600_R2","first-page":"293","article-title":"An audit of outcome of treatment in acromegaly.","volume":"86","author":"Bates","year":"1993","journal-title":"Q J Med"},{"key":"2020071618502440600_R3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","article-title":"Determinants of clinical outcome and survival in acromegaly.","volume":"41","author":"Rajasoorya","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618502440600_R4","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.","volume":"83","author":"Orme","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2265.2001.01218.x","article-title":"Growth hormone and the heart.","volume":"54","author":"Colao","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618502440600_R6","first-page":"249","article-title":"Anatomie pathologique, lesions et trouble cardiovasculaires de l\u2019acromegalie.","volume":"9","author":"Huchard","year":"1895","journal-title":"J Practiciens"},{"key":"2020071618502440600_R7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archinte.1938.00180100014002","article-title":"The heart in acromegaly.","volume":"61","author":"Courville","year":"1938","journal-title":"Arch Intern Med"},{"key":"2020071618502440600_R8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.7326\/0003-4819-34-6-1445","article-title":"Acromegaly and the heart: a clinical and pathologic study.","volume":"34","author":"Hejtmancik","year":"1951","journal-title":"Ann Intern Med"},{"key":"2020071618502440600_R9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-8703(80)90277-X","article-title":"Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients.","volume":"100","author":"Lie","year":"1980","journal-title":"Am Heart J"},{"key":"2020071618502440600_R10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0002-9343(79)90477-7","article-title":"Acromegaly and the heart. An echocardiographic study.","volume":"66","author":"Smallridge","year":"1979","journal-title":"Am J Med"},{"key":"2020071618502440600_R11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/0003-4819-81-1-11","article-title":"Acromegaly and cardiovascular disorders: a prospective study.","volume":"81","author":"McGuffin WLJr, Sherman","year":"1974","journal-title":"Ann Intern Med"},{"key":"2020071618502440600_R12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0002-9343(79)90742-3","article-title":"Echocardiographic assessment of cardiac anatomy and function in patients.","volume":"67","author":"Savage","year":"1979","journal-title":"Am J Med"},{"key":"2020071618502440600_R13","first-page":"41","article-title":"Acromegalic heart disease: influence of treatment of the acromegaly on the heart.","volume":"62","author":"Hayward","year":"1987","journal-title":"Q J Med"},{"key":"2020071618502440600_R14","first-page":"666","article-title":"Cardiac hypertrophy and function in asymptomatic acromegaly","volume":"12","author":"Morvan","year":"1991","journal-title":"Eur Heart J"},{"key":"2020071618502440600_R15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/14.1.26","article-title":"Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study.","volume":"14","author":"Fazio","year":"1993","journal-title":"Eur Heart J"},{"key":"2020071618502440600_R16","first-page":"193","article-title":"Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.","volume":"85","author":"Colao","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R17","first-page":"1426","article-title":"Cardiac effect of thyrotoxicosis in acromegaly.","volume":"85","author":"Marzullo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/hrt.62.3.185","article-title":"Subclinical cardiac dysfunction in acromegaly evidence for a specific disease of heart muscle.","volume":"62","author":"Rodrigues","year":"1989","journal-title":"Br Heart J"},{"key":"2020071618502440600_R19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03347663","article-title":"Acromegalic cardiopathy: a left ventricular scintigraphic study.","volume":"16","author":"Sicolo","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"2020071618502440600_R20","first-page":"575","article-title":"Cardiac effects of lanreotide, a slow release somatostatin analog, in acromegalic patients.","volume":"84","author":"Baldelli","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R21","first-page":"1518","article-title":"Impact of patient\u2019s age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study.","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0002-9149(99)00135-6","article-title":"Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog).","volume":"83","author":"Hradec","year":"1999","journal-title":"Am J Cardiol"},{"key":"2020071618502440600_R23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0003-4975(97)00788-1","article-title":"Heart valve operation in acromegaly.","volume":"64","author":"Ohtsuka","year":"1997","journal-title":"Ann Thor Surg"},{"key":"2020071618502440600_R24","first-page":"000","article-title":"Echocardiographic evaluation of left ventricular function in acromegaly patients [Abstract].","volume":"000","author":"Zlatareva","year":"2000","journal-title":"J Bulgarian Soc Endocrinol"},{"key":"2020071618502440600_R25","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(98)03356-X","article-title":"Growth hormone and prolactin excess.","volume":"352","author":"Colao","year":"1998","journal-title":"Lancet"},{"key":"2020071618502440600_R26","first-page":"526","article-title":"Criteria for cure of acromegaly: a consensus statement.","volume":"85","author":"Giustina","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R27","first-page":"1","volume":"862","journal-title":"WHO Tech Rep Ser"},{"key":"2020071618502440600_R28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)12131-1","article-title":"Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria.","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"2020071618502440600_R29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiography measurements.","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation"},{"key":"2020071618502440600_R30","volume-title":"Echocardiography, 5th Ed","author":"Feigenbaum","year":"1994"},{"key":"2020071618502440600_R31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/oxfordjournals.eurheartj.a060584","article-title":"Predictors of left ventricular mass in old age: an echocardiographic, clinical and biochemical investigation of a random population sample.","volume":"15","author":"Lindroos","year":"1994","journal-title":"Eur Heart J"},{"key":"2020071618502440600_R32","first-page":"784","article-title":"Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.","volume":"141","author":"Palmieri","year":"2001","journal-title":"Hypertension"},{"key":"2020071618502440600_R33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3143\/geriatrics.27.728","article-title":"Echocardiographic assessment of mitral annular calcification in hypertrophic cardiomyopathy with asymmetric septal hypertrophy and healthy elderly cases","volume":"27","author":"Matsumoto","year":"1990","journal-title":"Nippon Ronen Igakkai Zasshi"},{"key":"2020071618502440600_R34","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1210\/jcem.86.7.7635","article-title":"Acromegaly and cancer: not a problem.","volume":"86","author":"Melmed","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R35","first-page":"3419","article-title":"Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.","volume":"83","author":"Swearingen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7326\/0003-4819-117-9-719","article-title":"Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion.","volume":"117","author":"Lim","year":"1992","journal-title":"Ann Intern Med"},{"key":"2020071618502440600_R37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF03350250","article-title":"Acromegalic cardiopathy improves after treatment with increasing doses of octreotide.","volume":"14","author":"Pereira","year":"1991","journal-title":"J Endocrinol Invest"},{"key":"2020071618502440600_R38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jcem.84.1.5368","article-title":"Effects of one-year treatment with octreotide on cardiac performance in patients with acromegaly.","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R39","first-page":"3132","article-title":"Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.","volume":"86","author":"Colao","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502440600_R40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2265.2003.01689.x","article-title":"Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide.","volume":"85","author":"Colao","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618502440600_R41","first-page":"828","article-title":"Surgical treatment of valvular heart disease in patients with acromegaly.","volume":"9","author":"Cable","year":"2000","journal-title":"J Heart Valve Dis"},{"key":"2020071618502440600_R42","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","article-title":"Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)","volume":"83","author":"Singh","year":"2001","journal-title":"Am J Cardiol"},{"key":"2020071618502440600_R43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2265.2001.01343.x","article-title":"Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients.","volume":"55","author":"Minniti","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618502440600_R44","first-page":"1551","article-title":"Is the acromegalic cardiomyopathy reversible? Effect of 5 year normalization of growth hormone and insulin-like growth factor-I levels on cardiac performance.","volume":"86","author":"Colao","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/88\/7\/3196\/9149915\/jcem3196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/88\/7\/3196\/9149915\/jcem3196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:04:08Z","timestamp":1594958648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/88\/7\/3196\/2845370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,1]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2002-021099","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,1]]}}}